Literature DB >> 27170021

Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons.

Melanie R Walker1, Hui Li1, Suzy Teutsch1, Brigid Betz-Stablein1, Fabio Luciani1, Andrew R Lloyd1, Rowena A Bull2.   

Abstract

Hepatitis C virus (HCV) is a highly diverse pathogen that is classified into seven distinct genotypes. Simultaneous or sequential reinfection with multiple HCV genotypes is recognized in high-risk populations, such as injecting drug users (IDUs). Multiple infection is of clinical concern as different genotypes have various sensitivities to current antiviral therapies. Therefore, a better understanding of the frequency of multiple infection and of the genotypes currently being transmitted is clinically relevant. An Australian cohort of IDUs (n = 123), identified with primary incident infection, was followed for multiple infection by regular HCV RNA testing between 2005 and 2013. A total of 354 samples were tested. Sequencing of primary incident infections revealed that genotype 3a was the most common circulating genotype, followed by genotype 1a. Examination of longitudinally collected samples identified complex patterns of multiple infection, including reinfection and superinfection. In those with multiple infection, there was no apparent evidence of homotypic immunity conferring protection against reinfection of the same subtype. This study revealed frequent multiple infection in a high-risk prisoner cohort, illustrating the complex nature of HCV infection and reinfection and highlighting the need for pan-genotypic antiviral therapies.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27170021      PMCID: PMC4922113          DOI: 10.1128/JCM.00287-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients.

Authors:  J Chen; P H McGuinness; D J Koorey; K Rickard; B Wylie; G W McCaughan
Journal:  J Gastroenterol Hepatol       Date:  1997-02       Impact factor: 4.029

2.  Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.

Authors:  M Martinot-Peignoux; F Roudot-Thoraval; I Mendel; J Coste; J Izopet; G Duverlie; C Payan; J M Pawlotsky; C Defer; M Bogard; V Gerolami; P Halfon; Y Buisson; B Fouqueray; P Loiseau; J Lamoril; J J Lefrere; P Marcellin
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

3.  Change in hepatitis C virus genotype in injecting drug users.

Authors:  Campbell Aitken; Rhonda McCaw; Darren Jardine; Scott Bowden; Peter Higgs; Oanh Nguyen; Nick Crofts; Margaret Hellard
Journal:  J Med Virol       Date:  2004-12       Impact factor: 2.327

4.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

Review 5.  Natural history of chronic hepatitis C virus infection.

Authors:  Antonio Ascione; Teresa Tartaglione; Giovan Giuseppe Di Costanzo
Journal:  Dig Liver Dis       Date:  2007-09       Impact factor: 4.088

6.  The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.

Authors:  Peter Vickerman; Jason Grebely; Gregory J Dore; Rachel Sacks-Davis; Kimberly Page; David L Thomas; William O Osburn; Andrea L Cox; Campbell K Aitken; Matthew Hickman; Margaret Hellard
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

7.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

8.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

9.  The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis.

Authors:  François M J Lamoury; Brendan Jacka; Sofia Bartlett; Rowena A Bull; Arthur Wong; Janaki Amin; Janke Schinkel; Art F Poon; Gail V Matthews; Jason Grebely; Gregory J Dore; Tanya L Applegate
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

10.  Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

Authors:  Thijs J W van de Laar; Richard Molenkamp; Charlotte van den Berg; Janke Schinkel; Marcel G H M Beld; Maria Prins; Roel A Coutinho; Sylvia M Bruisten
Journal:  J Hepatol       Date:  2009-06-18       Impact factor: 25.083

View more
  6 in total

1.  Model-based estimation of superinfection prevalence from limited datasets.

Authors:  Daniel B Reeves; Amalia S Magaret; Alex L Greninger; Christine Johnston; Joshua T Schiffer
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

2.  Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.

Authors:  Tsung-Hua Yang; Yu-Jen Fang; Shih-Jer Hsu; Ji-Yuh Lee; Min-Chin Chiu; Jian-Jyun Yu; Chia-Chi Kuo; Chien-Hung Chen
Journal:  Open Forum Infect Dis       Date:  2020-07-17       Impact factor: 3.835

3.  Understanding the Determinants of BnAb Induction in Acute HCV Infection.

Authors:  Alexander P Underwood; Melanie R Walker; Nicholas A Brasher; Auda A Eltahla; Lisa Maher; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  Viruses       Date:  2018-11-21       Impact factor: 5.048

4.  A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.

Authors:  Sofia R Bartlett; Tanya L Applegate; Brendan P Jacka; Marianne Martinello; Francois Mj Lamoury; Mark Danta; Daniel Bradshaw; David Shaw; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Gail V Matthews; Jason Grebely
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

5.  Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.

Authors:  Melanie R Walker; Auda A Eltahla; Michael M Mina; Hui Li; Andrew R Lloyd; Rowena A Bull
Journal:  Viruses       Date:  2020-01-08       Impact factor: 5.048

6.  Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies.

Authors:  Melanie R Walker; Preston Leung; Auda A Eltahla; Alexander Underwood; Arunasingam Abayasingam; Nicholas A Brasher; Hui Li; Bing-Ru Wu; Lisa Maher; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.